Sarepta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. 

CEO
Douglas S. Ingram
CEODouglas S. Ingram
Employees
1,314
Employees1,314
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1980
Founded1980
Employees
1,314
Employees1,314

SRPT Key Statistics

Market cap
12.33B
Market cap12.33B
Price-Earnings ratio
-21.15
Price-Earnings ratio-21.15
Dividend yield
Dividend yield
Average volume
638.10K
Average volume638.10K
High today
$131.16
High today$131.16
Low today
$127.83
Low today$127.83
Open price
$131.16
Open price$131.16
Volume
786.42K
Volume786.42K
52 Week high
$159.89
52 Week high$159.89
52 Week low
$55.25
52 Week low$55.25

SRPT News

Yahoo Finance 3d
A Comprehensive Look at Sarepta's Growth and Innovation - Yahoo Finance

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is an American pharmaceutical company leading the global Duchenne muscular dystrophy, or DMD, treatment market. The co...

A Comprehensive Look at Sarepta's Growth and Innovation - Yahoo Finance
Simply Wall St 5d
We Might See A Profit From Sarepta Therapeutics, Inc. Soon - Simply Wall St

We feel now is a pretty good time to analyse Sarepta Therapeutics, Inc.'s ( ) business as it appears the company may be on the cusp of a considerable accomplish...

We Might See A Profit From Sarepta Therapeutics, Inc. Soon - Simply Wall St

Analyst ratings

83%

of 23 ratings
Buy
82.6%
Hold
17.4%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.